Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Classical hematology 4Lymphoid 2Plasma cell 1Other hematologic neoplasm 1Other 1Myeloid 1CNS 1

Conditions

Obesity 60Neoplasms 20Overweight 17Polycystic Ovary Syndrome 11Dyspnea 10Sexual Dysfunction, Physiological 9Prostatic Neoplasms 7Motor Activity 7Hypertension 7Endometrial Neoplasms 7Breast Neoplasms 7Diabetes Mellitus, Type 2 6Mucositis 5Metabolic Syndrome 5Diabetes Mellitus 5Pulmonary Disease, Chronic Obstructive 4Lung Neoplasms 4Depression 4Constipation 4Cardiovascular Diseases 4Weight Loss 3Stomatitis 3Renal Insufficiency, Chronic 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Opioid-Induced Constipation 3Non-alcoholic Fatty Liver Disease 3Myasthenia Gravis 3Insulin Resistance 3Heart Failure 3Endometrial Hyperplasia 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × beta-Thalassemia × Other × Clear all
NCT06539169 2024-11-14

FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases

xCures

Recruiting
1,000 enrolled
Classical hematologyOtherPlasma cell

Alzheimer Disease, Amyloidosis, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Cystic Fibrosis, Ehlers-Danlos Syndrome, Gaucher Disease, Glycogen Storage Disease Type II, Huntington Disease, Myasthenia Gravis, Gangliosidosis, GM1, alpha-Thalassemia, beta-Thalassemia, Muscular Dystrophy, Duchenne, Insomnia, Fatal Familial, Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon âš¡